Amerikanische Gesellschaft für Hirudotherapie

Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin

Research article published in Analytical chemistry (2011)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomik & ProteomikKang Y et al. · Analytical chemistry, 2011

Abstract

Contamination of heparin with oversulfated chondroitin sulfate (OSCS) became a matter of grave concern in the medical field after many fatal responses to OSCS tainted heparin products occurred during the 2007-2008 period. Even though standard lab-based analytical techniques such as nuclear magnetic resonance (NMR) and strong anion-exchange high performance liquid chromatography (SAX-HPLC) have proven useful for monitoring the OSCS content in heparin products, an easy-to-use, quick, portable, and cost-efficient method is still needed for on-site monitoring during and after the heparin production. In this report, a disposable strip-type electrochemical polyion sensor is described for detection of low levels of OSCS contamination in heparin. A magnetic actuator is incorporated into this simple electrode-based microfluidic device in order to create the mixing effect necessary to achieve equilibrium potential changes of the sensor within a microfluidic channel. The planar membrane electrode detector within the sample channel is prepared with a tridodecylmethylammonium chloride (TDMAC)-doped poly(vinyl chloride) (PVC) membrane essentially equivalent to previously reported polyanion-sensitive electrodes. When the concentration of heparin applied to the single-use strip device is 57 mg/mL (in only 20 μL of sample), the same concentration recommended in the NMR analysis protocol for detecting OSCS in heparin, the detection limit is 0.005 wt % of OSCS, which is ca. 20 times lower than the reported detection limit of the NMR method.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
Indexed MeSH termsChondroitin SulfatesElectrochemical TechniquesElectrodesHeparinMagneticsMicrofluidic Analytical TechniquesPolyelectrolytesPolymersPolyvinyl ChlorideQuaternary Ammonium Compounds

Zusammenfassung

Contamination of heparin with oversulfated chondroitin sulfate (OSCS) became a matter of grave concern in the medical field after many fatal responses to OSCS tainted heparin products occurred during the 2007-2008 period.

Warum dies für die Hirudotherapie relevant ist

This methodological study details the development of a disposable, potentiometric strip test for detecting oversulfated chondroitin sulfate (OSCS) impurities in heparin products. The device utilizes an electrochemical polyion sensor within a microfluidic channel to achieve highly sensitive, on-site monitoring of heparin contamination. This research is focused exclusively on improving the safety and quality control of pharmaceutical heparin. Consequently, it holds no relevance to the American Society of Hirudotherapy, as the study does not involve leeches, hirudotherapy, or leech-derived anticoagulants. There is no mention of the leech secretome or any comparative analysis with hirudin, making any connection to clinical leech applications entirely absent from the abstract.

Zitation

Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin

Kang Y et al. · Analytical chemistry, 2011

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.